• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials

    • Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials
    • Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials
    • Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials storehouse
    • Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials quality testing
    • Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials quality testing
    • Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials certificate

    Product Overview:

    Ceftriaxone Sodium Powder is a water-soluble beta-lactam cephalosporin.Veterinary Medicine Ceftriaxone Sodium is a non-gastrointestinal, semi-synthetic, broad-spectrum, long-acting, third-generation cephalosporin antibiotic used for the treatment of respiratory infections, urinary tract infections, gonorrhoea, and for preoperative Ceftriaxone Sodium Raw Materials is used for the treatment of respiratory tract infections, urinary tract infections, biliary tract infections caused by sensitive pathogens, as well as abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections, septicaemia, meningitis, etc., and the prevention of perioperative infections.

    Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials Attributes

    Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials

    CAS: 74578-69-1

    MF: C18H19N8NaO7S3

    Ceftriaxone Sodium

    MW: 578.57

    EINECS:  277-930-0

    Specification​: 99% min Ceftriaxone Sodium

    Sample: Ceftriaxone Sodium Powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Portal:https://henrikang.en.made-in-china.com/

    Veterinary Medicine Ceftriaxone Sodium Powder CAS 74578-69-1 Raw Materials Details

    Ceftriaxone Sodium Powder Usage and Synthesis.

    Ceftriaxone Sodium Powder is a water-soluble beta-lactam cephalosporin.Veterinary Medicine Ceftriaxone Sodium is a non-gastrointestinal, semi-synthetic, broad-spectrum, long-acting, third-generation cephalosporin antibiotic used for the treatment of respiratory infections,

    urinary tract infections, gonorrhoea, and for preoperative Ceftriaxone Sodium Raw Materials is used for the treatment of respiratory tract infections, urinary tract infections, biliary tract infections caused by sensitive pathogens, as well as abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections, septicaemia, meningitis, etc., and the prevention of perioperative infections.

    Ceftriaxone Sodium Powder

    Uses and functions of Ceftriaxone Sodium Powder.

    Ceftriaxone sodium is a water-soluble β-lactam cephalosporin, a non-gastrointestinal, semi-synthetic, broad-spectrum, long-lasting third-generation cephalosporin antibiotic, very sensitive to most Gram-positive and negative bacteria, with a broad antibacterial spectrum, strong antibacterial effect, resistance to enzymatic degradation, low toxicity, strong tissue penetration, and long half-life. 

    Ceftriaxone Sodium Powder

    The β-lactam structure of ceftriaxone acts on the carboxypeptidase, peptide chain endonuclease, transpeptidase of bacterial cytoplasmic membrane, these enzymes are involved in cell synthesis and cell division, which leads to cell wall defects and cell death, and inhibits mucopeptide synthesis of bacterial cell wall to achieve the therapeutic effect, and it has achieved good therapeutic effect in the treatment of lower respiratory tract infections, skin tissues, urinary tract infection, bone and joint infections, as well as bacterial septicemia. Good therapeutic effect.

    Pharmacological Effects of Ceftriaxone Sodium Powder.

    This product is a third generation cephalosporin antibiotic. It has strong activity against Enterobacteriaceae. The MIC90 for Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Flouraudi citrobacter, indole-positive Aspergillus, Prevotella spp. and Serratia spp. ranged from 0.12 to 0.25 mg/L. 

    Ceftriaxone Sodium Powder

    Enterobacter cloacae, Enterobacteriaceae spp. and Pseudomonas aeruginosa were poorly susceptible to the product. It has strong antibacterial effect on Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis, and also has good effect on Streptococcus haemolyticus and Pneumococcus. 

    The MIC for Staphylococcus aureus is 2-4mg/L. Methicillin-resistant Staphylococcus aureus and Enterococcus are resistant to the product. The majority of S. fragilis are resistant to this product.

    Production method of Ceftriaxone Sodium Powder.

    Ceftriaxone sodium is a 3rd generation cephalosporin antibiotic with broad-spectrum and high efficacy, it is bactericidal against many Gram-positive, negative and anaerobic bacteria, and its antibacterial effect is enhanced by its high degree of stabilisation against most of the β-lactamases produced by bacteria.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,